Sherry Shen, MD, explains why invasive lobular breast cancer needs histology-specific clinical trials and how its unique biology shapes care.
Sherry Shen
Advertisement
Articles by Sherry Shen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Personalized mRNA Vaccine Intismeran Plus Pembro Cuts Melanoma Recurrence
2
FDA Alignment Reached on Phase 3 Design for RGT-61159 in ACC
3
Sofetabart Mipitecan Elicits Responses Across FRα Levels in Ovarian Cancer
4
Onvansertib Receives FDA Orphan Drug Designation for CMML
5